Mather Group, Llc. Novartis Ag Transaction History

Mather Group, Llc.

$7.74 Billion
Q3 2024

A detailed history of Mather Group, Llc. transactions in Novartis Ag stock. As of the latest transaction made, Mather Group, Llc. holds 7,538 shares of NVS stock, worth $786,062. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,538

Previous 10,599 28.88%

Holding current value

$786,062

Previous $1.13 Million 23.14%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$106.13 - $120.89 $324,863 - $370,044	-3,061 Reduced 28.88%	7,538 $867,000
Q2 2024 Jul 08, 2024	BUY	$92.57 - $107.37 $281,968 - $327,049	3,046 Added 40.33%	10,599 $1.13 Million
Q1 2024 Apr 08, 2024	SELL	$95.27 - $108.47 $183,108 - $208,479	-1,922 Reduced 20.28%	7,553 $730,000
Q4 2023 Feb 05, 2024	BUY	$92.27 - $101.54 $157,966 - $173,836	1,712 Added 22.05%	9,475 $956,000
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $54,943 - $60,975	580 Added 8.07%	7,763 $790,000
Q2 2023 Aug 08, 2023	BUY	$92.52 - $104.91 $54,494 - $61,791	589 Added 8.93%	7,183 $724,000
Q1 2023 May 09, 2023	BUY	$80.03 - $92.81 $164,301 - $190,538	2,053 Added 45.21%	6,594 $606,000
Q4 2022 Mar 10, 2023	SELL	$75.55 - $92.52 $230,427 - $282,186	-3,050 Reduced 40.18%	4,541 $411,000
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $89,009 - $104,101	-1,193 Reduced 13.58%	7,591 $577,000
Q2 2022 Aug 16, 2022	BUY	$80.52 - $93.75 $10,226 - $11,906	127 Added 1.47%	8,784 $743,000
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $801 - $906	-10 Reduced 0.12%	8,657 $760,000
Q4 2021 Feb 15, 2022	BUY	$79.7 - $88.13 $242,925 - $268,620	3,048 Added 54.24%	8,667 $758,000
Q3 2021 Nov 04, 2021	BUY	$81.78 - $95.14 $10,631 - $12,368	130 Added 2.37%	5,619 $459,000
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $1,534 - $1,694	-18 Reduced 0.33%	5,489 $501,000
Q1 2021 May 14, 2021	SELL	$83.5 - $98.47 $7,181 - $8,468	-86 Reduced 1.54%	5,507 $471,000
Q4 2020 Feb 12, 2021	SELL	$78.07 - $94.43 $8,197 - $9,915	-105 Reduced 1.84%	5,593 $528,000
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $4,517 - $5,005	55 Added 0.97%	5,698 $495,000
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $1,133 - $1,275	14 Added 0.25%	5,643 $493,000
Q1 2020 May 14, 2020	BUY	$70.67 - $99.01 $199,784 - $279,901	2,827 Added 100.89%	5,629 $464,000
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $236,348 - $267,226	2,802 New	2,802 $265,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.

Account